Correlation Between Beta Drugs and Mangalam Organics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Mangalam Organics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Mangalam Organics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beta Drugs and Mangalam Organics Limited, you can compare the effects of market volatilities on Beta Drugs and Mangalam Organics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Mangalam Organics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Mangalam Organics.

Diversification Opportunities for Beta Drugs and Mangalam Organics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Beta and Mangalam is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Mangalam Organics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mangalam Organics and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Mangalam Organics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mangalam Organics has no effect on the direction of Beta Drugs i.e., Beta Drugs and Mangalam Organics go up and down completely randomly.

Pair Corralation between Beta Drugs and Mangalam Organics

Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.01 times more return on investment than Mangalam Organics. However, Beta Drugs is 1.01 times more volatile than Mangalam Organics Limited. It trades about 0.09 of its potential returns per unit of risk. Mangalam Organics Limited is currently generating about 0.01 per unit of risk. If you would invest  63,450  in Beta Drugs on October 25, 2024 and sell it today you would earn a total of  127,580  from holding Beta Drugs or generate 201.07% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.79%
ValuesDaily Returns

Beta Drugs  vs.  Mangalam Organics Limited

 Performance 
       Timeline  
Beta Drugs 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.
Mangalam Organics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mangalam Organics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Beta Drugs and Mangalam Organics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Beta Drugs and Mangalam Organics

The main advantage of trading using opposite Beta Drugs and Mangalam Organics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Mangalam Organics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mangalam Organics will offset losses from the drop in Mangalam Organics' long position.
The idea behind Beta Drugs and Mangalam Organics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated